Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

ANGPTL4: a new mode in the regulation of intravascular lipolysis

Research output: Contribution to journalReviewResearchpeer-review

  1. Polygenic risk scores: how much do they add?

    Research output: Contribution to journalReviewResearchpeer-review

  2. Impact of metabolic dysfunction on cognition in humans

    Research output: Contribution to journalReviewResearchpeer-review

  3. Lipoprotein(a): is it more, less or equal to LDL as a causal factor for cardiovascular disease and mortality?

    Research output: Contribution to journalReviewResearchpeer-review

  4. Apolipoprotein M/sphingosine-1-phosphate: novel effects on lipids, inflammation and kidney biology

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Remnant lipoproteins

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Electrostatic sheathing of lipoprotein lipase is essential for its movement across capillary endothelial cells

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Optimization and Evaluation of Al18F Labeling Using a NOTA—or RESCA1-Conjugated AE105 Peptide Antagonist of uPAR

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Expression and one-step purification of active LPL contemplated by biophysical considerations

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. The Urokinase Receptor (uPAR) as a "Trojan Horse" in Targeted Cancer Therapy: Challenges and Opportunities

    Research output: Contribution to journalReviewResearchpeer-review

View graph of relations

PURPOSE OF REVIEW: Lipoprotein lipase (LPL) is the rate-limiting enzyme for intravascular processing of circulating triglyceride-rich lipoproteins (TRLs). One emerging strategy for therapeutic lowering of plasma triglyceride levels aims at increasing the longevity of LPL activity by attenuating its inhibition from angiopoietin-like proteins (ANGPTL) 3, 4 and 8. This mini-review focuses on recent insights into the molecular mechanisms underpinning the regulation of LPL activity in the intravascular unit by ANGPTLs with special emphasis on ANGPTL4.

RECENT FINDINGS: Our knowledge on the molecular interplays between LPL, its endothelial transporter GPIHBP1, and its inhibitor(s) ANGPTL4, ANGPTL3 and ANGPTL8 have advanced considerably in the last 2 years and provides an outlined on how these proteins regulate the activity and compartmentalization of LPL. A decisive determinant instigating this control is the inherent protein instability of LPL at normal body temperature, a property that is reciprocally impacted by the binding of GPIHBP1 and ANGPTLs. Additional layers in this complex LPL regulation is provided by the different modulation of ANGPTL4 and ANGPTL3 activities by ANGPTL8 and the inhibition of ANGPTL3/8 complexes by apolipoprotein A5 (APOA5).

SUMMARY: Posttranslational regulation of LPL activity in the intravascular space is essential for the differential partitioning of TRLs across tissues and their lipolytic processing in response to nutritional cues.

Original languageEnglish
JournalCurrent Opinion in Lipidology
Volume33
Issue number2
Pages (from-to)112-119
Number of pages8
ISSN0957-9672
DOIs
Publication statusPublished - 1 Apr 2022

Bibliographical note

Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

    Research areas

  • ANGPTL4, GPIHBP1, intravascular lipolysis, lipoprotein lipase, protein unfolding

ID: 69920901